Warning: session_start(): open(/opt/alt/php74/var/lib/php/session/sess_0f4d7f5012900a4bbee3a1760859f562, O_RDWR) failed: Disk quota exceeded (122) in /home/useaicwl/public_html/wp-content/themes/mushroomstocks/functions.php on line 278

Warning: session_start(): Failed to read session data: files (path: /opt/alt/php74/var/lib/php/session) in /home/useaicwl/public_html/wp-content/themes/mushroomstocks/functions.php on line 278
Changing Tides: Increasing support for marijuana - Mushroomstocks | Mushroomstocks
Albert Labs announces Strategic Investment from Cantheon Capital LLC for First In-Human TrialsMindMed Reports Full Year 2022 Financial Results and Business HighlightsCybin to Participate in the Oppenheimer 33rd Annual Healthcare ConferenceNuminus to Participate in the Sequire Cannabis & Psychedelics Conference on Wednesday, April 5, 2023Braxia Scientific Provides Update on Proposed Irwin Transaction; Company Retains Strategic Clinical Assets and Ketamine Numinus Announces Four Peer-Reviewed Publications from its Chief Clinical Officer in 2023Irwin Naturals Signs Letter of Intent to Acquire Braxia ScientificNuminus Wellness Inc. Reports Q1 2023 ResultsIrwin Naturals and Braxia Scientific Announce Partnership for In-Human Clinical Studies Supporting Pharmaceutical CompanNuminus Develops Mushroom Tea for Use in Psychedelic ResearchIs the Psychedelic Sector Poised for a Comeback?!?PSYC + Nucleus Form New Partnership to Develop and Launch Psychedelic FinderWhat You Need to Know About Numinus Wellness…Numinus provides update on acquisition integration and announces new client financing optionsPSYC Corp’s Psychedelic Spotlight Surpasses One Million Page Views for Fourth Consecutive MonthNuminus to Participate in the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14, 2022The Psychedelic Sector is Quietly Outperforming the S&P 500PSYC Completes and Publishes 2021 Audited Financials; Will Begin Audit of Q1 & Q2 2022Numinus to Participate in the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14, 2022PSYC’s Bonfire Platform Development Progresses; Will Host Free Virtual Community Event on August 29th
Back

Changing Tides: Increasing support for marijuana

Jan 10, 2015 • 11:02 PM EST
!!!!!!.png
2 MIN READ  •  By Michael Berger
Share Share - Facebook Share - Twitter

As of January 1, 2015, 23 states and Washington D.C. have laws legalizing medical marijuana to some degree and 4 states have legalized marijuana for recreational use (Colorado, Washington, Alaska, and Oregon). As you can see, marijuana is becoming more accepted by the nation due to the abundant amount of data supporting its medical benefits. It is interesting to note the increasing number of people who support legalizing marijuana and the declining number of people who oppose its legalization.

Changing Tides

The Democratic and Republican parties may have a difficult time agreeing on issues but both have increased their acceptance of the legalization of marijuana. This will promote the effective legalization of marijuana on a federal level.

On December 11th, 2014, the House of Representatives and Senate reached a bipartisan agreement on a spending bill. One of the provisions in the bill was defunding DEA enforcement in states where marijuana is legal. This will enable businesses in those states to grow without interference. Americans for Safe Access claims that under the Obama Administration, they have spent $300 million on enforcement in states that have legalized marijuana. Patients and medical marijuana providers will no longer fear federal prosecution.

Outlook

Marijuana is currently classified as a schedule I drug, Schedule I substances are those that meet the following criteria:

  • The drug or substance has a high potential for abuse.
  • The drug or substance has no currently accepted medical use in treatment in the United States.
  • There is a lack of accepted safety for use of the drug or substance under medical supervision

Cocaine, methamphetamine, and OxyContin are some of the drugs categories as a Schedule II substance. This means that marijuana is more dangerous that Meth…something is off here.

In late October, United States District Judge Kimberly Mueller of the Eastern District of California, listened to testimonies during a five day evidentiary hearing to determine if the Schedule I dangerous drug classification imposed on the cannabis plant by the Drug Enforcement Administration in 1970 is unconstitutional.

Judge Mueller is expected to deliver her decision in early 2015. Technial420 expects that she will be in favor of cannabis NOT being a Schedule I substance. The reason why we are confident of this is because:

  1. On the third day of the hearing, both federal prosecutors and the defense agreed that cannabis has medicinal benefits. This completely contradicts the definition of a Schedule I substance.
  2. Research has shown that cannabis has medical benefits. GW Pharmaceutical (GWPH: NASDAQ) manufactures the first cannabis-derived prescription drug that is sold in over 25 countries!
  3. Medical experts such as Dr. Sanjay Gupta have stated that marijuana has medical benefits.

 

http://www.plunkettresearch.com/sports-recreation-leisure-market-research/industry-statistics

http://www.washingtonpost.com/blogs/wonkblog/wp/2014/10/24/the-marijuana-industry-could-be-bigger-than-the-nfl-by-2020/

http://www.rollingstone.com/politics/news/the-great-marijuana-experiment-a-tale-of-two-drug-wars-20140103

http://www.forbes.com/sites/kellyphillipserb/2014/03/11/its-no-toke-colorado-pulls-in-millions-in-marijuana-tax-revenue/

http://money.cnn.com/2014/02/20/news/economy/marijuana-taxes-colorado/index.html

http://www.mainstreet.com/article/congress-passes-major-medical-marijuana-reform-before-holidays

http://medical-dictionary.thefreedictionary.com/Schedule+I+drug

http://blog.sfgate.com/smellthetruth/2014/12/12/congress-ends-war-on-medical-marijuana/

Share Share - Facebook Share - Twitter

Tags

Authored By

Michael Berger

Michael Berger is Managing Partner of StoneBridge Partners, LLC and Founder of Mushroomstocks.com. Prior to entering the cannabis industry, Michael was an Equity Research Analyst at Raymond James Financial covering the Energy Sector. Michael has been featured in publications such as The Street, Bloomberg, US Money News, and hosts various cannabis events across North America.

Comments

Top Stories

Get the Latest Cannabis News & Stock Picks.

Enter your email below to join the official Mushroomstocks newsletter.

 All good -- no spamming here.

The psychedelics sector is starting to take off as smart money begins to position itself across the industry.

Stay updated with all latest updates,upcoming events & much more.
Subscribe
SUBSCRIBE NOW
close-link

Fatal error: Uncaught ErrorException: md5_file(/home/useaicwl/public_html/wp-content/litespeed/css/b403e0d3728cd90ab24702d8da689b7a.css.tmp): failed to open stream: No such file or directory in /home/useaicwl/public_html/wp-content/plugins/litespeed-cache/src/optimizer.cls.php:126 Stack trace: #0 [internal function]: litespeed_exception_handler(2, 'md5_file(/home/...', '/home/useaicwl/...', 126, Array) #1 /home/useaicwl/public_html/wp-content/plugins/litespeed-cache/src/optimizer.cls.php(126): md5_file('/home/useaicwl/...') #2 /home/useaicwl/public_html/wp-content/plugins/litespeed-cache/src/optimize.cls.php(797): LiteSpeed\Optimizer->serve('https://mushroo...', 'css', true, Array) #3 /home/useaicwl/public_html/wp-content/plugins/litespeed-cache/src/optimize.cls.php(319): LiteSpeed\Optimize->_build_hash_url(Array) #4 /home/useaicwl/public_html/wp-content/plugins/litespeed-cache/src/optimize.cls.php(252): LiteSpeed\Optimize->_optimize() #5 /home/useaicwl/public_html/wp-includes/class-wp-hook.php(310): LiteSpeed\Optimize->f in /home/useaicwl/public_html/wp-content/plugins/litespeed-cache/src/optimizer.cls.php on line 126